首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy and safety of polyethylene glycol loxenatide monotherapy in type 2 diabetes patients: A multicentre,randomized, double-blind,placebo-controlled phase 3a clinical trial
Authors:Ying Shuai MD  Gangyi Yang MD  Qiu Zhang MD  Wei Li MD  Yong Luo MD  Jianhua Ma MD  Daoxiong Chen MD  Jialin Yang MD  Xinjun Wang MD  Ji Hu MD  Ning Xu MD  Wenying Yang MD
Affiliation:1. China-Japan Friendship Hospital, Beijing, China;2. Department of Endocrinology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China;3. Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, China;4. Department of Endocrinology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China;5. The Center of Clinical Research of Endocrinology and Metabolic Diseases in Chongqing and Department of Endocrinology, Chongqing Three Gorges Central Hospital, Chongqing, China;6. Nanjing First Hospital, Nanjing, China;7. Department of Endocrinology, People's Hospital of Hainan, Haikou, China;8. Department of Endocrinology, Central Hospital of Minhang District, Minhang Hospital Affiliated to Fudan University, Shanghai, China;9. The First Affiliated Hospital of Hainan Medical University, Haikou, China;10. Department of Endocrinology, The Second Affiliated Hospital of Soochow University, Suzhou, China;11. Department of Endocrinology Medicine, Lianyungang First People's Hospital, Affiliated Hospital of Xuzhou Medical College, Lianyungang, China
Abstract:
Keywords:Chinese   GLP-1   PEX168   randomized controlled trial   type 2 diabetes
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号